Key stats
About AXA-ACT BIO.EQ. TBCDLA
Expense ratio
0.70%
Home page
Inception date
Sep 27, 2022
ISIN
IE000SBHVL31
The investment objective of the Fund is to seek long-term capital growth from an actively managed portfolio of sustainable investments comprising listed equity and equity-related securities, including companies that are acting positively for biodiversity by reducing and/or limiting the negative impact of human activities on biodiversity.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Electronic Technology
Technology Services
Health Technology
Producer Manufacturing
Stocks99.31%
Electronic Technology15.74%
Technology Services15.34%
Health Technology14.39%
Producer Manufacturing12.60%
Finance9.14%
Process Industries8.27%
Retail Trade5.22%
Consumer Non-Durables4.61%
Industrial Services4.47%
Utilities2.18%
Transportation1.96%
Non-Energy Minerals1.09%
Consumer Durables1.08%
Consumer Services1.07%
Commercial Services0.96%
Communications0.91%
Health Services0.29%
Bonds, Cash & Other0.69%
Miscellaneous0.46%
Cash0.23%
Stock breakdown by region
North America66.31%
Europe16.23%
Asia14.65%
Oceania1.53%
Africa0.83%
Latin America0.46%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history